Immunomodulatory effects of oestrogen in prostatic cancer: update and further consideration.
The results of recent experimental and clinical studies provided further evidence that alterations of the endocrine environment may have profound effects on the immunogenicity of tumour and host responsiveness in patients with prostatic cancer are presented. The initially suggested immunomodulatory effects of hormones as related to patients with prostatic cancer are considered further.
D000951:Antigens, Neoplasm / Q000276:immunology; D002369:Castration; D004054:Diethylstilbestrol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007165:Immunosuppression Therapy; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery
D000951:Antigens, Neoplasm; D004054:Diethylstilbestrol; C004955:fosfestrol